SHARE:  
Join Our Email List

DEDICATED TO CURING NEUROENDOCRINE CANCER
OCTOBER 2015

NEW NAME.  NEW LOOK.
SAME CRUCIAL MISSION. 
NEUROENDOCRINE TUMOR RESEARCH FOUNDATION

The Caring for Carcinoid Foundation is now the Neuroendocrine Tumor Research Foundation! The name change comes after receiving input from patients, families, NET specialists, and researchers that a new name would honor the commitment to the vital work, but also reflect the range of patients and families dealing with NETs. Our new name is more inclusive of all types of neuroendocrine cancer and better reflects the current medical terminology for the disease. It is important that all those who are affected by neuroendocrine cancer, as well as all NET researchers, feel that they are part of our community. 

Along with the name change of the organization, we are excited to be launching a new website, logo, and brand identity. Our goal is to provide a simple, easily navigable website in order to deliver the resources and information patients and researchers need in a quick and efficient way. Our mission to fund research to discover cures for carcinoid, pancreatic, and related neuroendocrine cancers is as important as ever. Thank you for being a part of the Caring for Carcinoid, and now NET Research Foundation, community. Join us for a week of online activities, as we celebrate our history and embrace our ongoing vital mission. We encourage you to visit the new site regularly, as it continues to grow with updated content and new features over the coming weeks.  Explore our new website!  

CFCF Researchers Dr. Diane Reidy Lagunes, Memorial Sloan Kettering Cancer Center, and Dr. Pamela Kunz, Stanford University Cancer Institute, discuss immunotherapy for NETs on a NANETS panel.
NANETS SYMPOSIUM 2015
Progress and Possibility

The recently concluded 2015 Symposium of the North American Neuroendocrine Tumor Society (NANETS) was the largest gathering of NET specialists hosted by the Society. In opening the conference's Clinical Science Symposium, Dr. George Fisher, Stanford Professor and NETRF Scientific Advisory Chair, reflected on the enormous progress over the last few years: from relatively few trials in NETs to the day's presentations on three successful trials.  Read More
2015 BOSTON MARATHON JIMMY FUND WALK
Six Days Left to Support the NETwalkers Alliance Team

This year's Jimmy Fund Walk took place on September 27, 2015. The goal is to raise $8.2 million for research and patient care. The NETwalkers Alliance team, led by longtime NETRF friend Harry Proudfoot, has already raised over $66,000! The team walked to support neuroendocrine cancer research at the Dana-Farber Cancer Institute. Donations will be accepted through the end of October.  Donate to the NETwalkers Alliance Team.
NVS logo
We are pleased to announce that this eUpdate is supported by Novartis Pharmaceutical Corporation.

The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers.

NETRF is a 501(c)(3) organization. All contributions are tax-deductible to the extent allowed by law.
To learn more, view our: Audited Financial Statements and IRS Form 990.